KTOV
Kitov Pharmaceuticals

29,666
Mkt Cap
$12.74M
Volume
1,990.00
52W High
$2.08
52W Low
$0.3023
PE Ratio
-0.54
KTOV Fundamentals
Price
$0.5002
Prev Close
$0.49
Open
$0.50
50D MA
$0.6698
Beta
0.80
Avg. Volume
109,096.20
EPS (Annual)
-$0.9105
P/B
0.35
EV/EBITDA
-0.19
Loading...
Loading...
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
20

Frequently Asked Questions

What is Market Cap of Kitov Pharma Ltd - ADR?
What is the 52-week high for Kitov Pharma Ltd - ADR?
What is the 52-week low for Kitov Pharma Ltd - ADR?
What is Kitov Pharma Ltd - ADR stock price today?
What was Kitov Pharma Ltd - ADR stock price yesterday?
What is the PE ratio of Kitov Pharma Ltd - ADR?
What is the Price-to-Book ratio of Kitov Pharma Ltd - ADR?
What is Kitov Pharma Ltd - ADR's EBITDA?
What is the 50-day moving average of Kitov Pharma Ltd - ADR?
How many employess does Kitov Pharma Ltd - ADR has?

Latest KTOV News

View
No KTOV news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.